"IU Health Arnett Hospital has been a member of the Lafayette community since 1922. Find visitor information, a hospital map and learn about amenities available."

During the past decade, IU Health Arnett conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "IU Health Arnett" #1 sponsor was "Fairbanks Institute" with 1 trials, followed by "Merit Medical Systems, Inc." with 1 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored, "National Cancer Institute (NCI)" with 1 trials sponsored and "Richard Zellars" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "IU Health Arnett" #1 collaborator was "BioCrossroads" with 1 trials as a collaborator, "Indiana University School of Medicine" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator, "Regenstrief Institute, Inc." with 1 trials as a collaborator and "Richard M. Fairbanks Foundation" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "IU Health Arnett" are "Breast Cancer" (2 trials), "Adenocarcinoma of the Breast" (1 trials), "Coronary Artery Disease" (1 trials), "Healthy" (1 trials) and "Heart Disease" (1 trials). Many other conditions were trialed in "IU Health Arnett" in a lesser frequency.

Most popular intervention types in "IU Health Arnett" are "Drug" (2 trials), "Biological" (1 trials), "Device" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "CentrosFLO Long Term Hemodialysis Catheter" (1 trials), "Cyclophosphamide" (1 trials), "Docetaxel" (1 trials), "Doxorubicin" (1 trials) and "PBI with concurrent chemotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "IU Health Arnett" are 3 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "IU Health Arnett". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in IU Health Arnett, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IU Health Arnett, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".